Clinical Trials for Thymus Cancer
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Thymus Cancer is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Thymus Cancer:
- Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - octreotide,prednisone
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,busulfan,cyclophosphamide,cyclosporine,melphalan,methylprednisolone
- Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel
- Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs - This study has been completed (Current: 23 Nov 2006) - doxorubicin
- Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - Premetrexed (Alimta)
- Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Gleevec
- Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Octreotide
- A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,Erlotinib
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Preoperative Treatment of Patients With High Risk Thymoma. - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin and etoposide
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Thymus Cancer:
The trial data on this page has been sourced from
What causes cancer and why is it so hard to treat? Leading experts provide an overview of cancer, from what goes wrong in a cell's genetic...
Stress takes its toll by making us anxious, depressed and not able to function as fully as we'd like. What many don't know is that stress can...
Health insurance is important to everyone, especially people with chronic conditions like Crohn's disease and ulcerative colitis. Tune in to...
Sleep is necessary to feel refreshed, but now we know sleep actually impacts the way the body functions. Sleeping poorly can affect how often you get...
See full list of 4 related videos
» Next page: External links relating to Thymus Cancer
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
